Market assessment and pharmaceutical consulting services in Estonia

With over two decades of experience in the Central and Eastern European healthcare sector, Grove’s expertise in providing market assessment and pharmaceutical consulting services in the region is proven by the success of those with which it has worked over that time. Grove’s full-time in-country expertise and the resultant depth and breadth of knowledge of the Estonian healthcare sector is key to its clients’ success. Grove’s ad-hoc consulting services primarily relate to the provision of on-going support for market development.

Over the past twenty years, Grove’s regulatory consultants have provided expert advice and guidance to clients across the Central and Eastern European region. Questions addressed have covered the following areas and more:


Grove’s industry experts work as a team to provide a range of services for those either looking to enter the pharma market or develop their presence further into new areas within the market. Services include:
  • Market entry studies
  • Opportunity evaluation
  • Regulatory intelligence
  • Regulatory risk assessment
  • Regulatory strategies
  • Regulatory consulting for compassionate (named patient) use programs


Grove’s in-country consultants work with clients established within the Estonian market to develop their business in a number of areas. Key areas of expertise include:
  • PR and marketing support
  • Monitoring market and industry change
  • Sales force training
  • Medical device consulting
  • Named patient/compassionate use supply
  • Orphan drugs
  • Access to key opinion leaders and healthcare decision makers
  • Pricing and reimbursement monitoring
  • Competitor analysis
  • Product portfolio expansion
Grove’s expert consulting spans across the following product areas:
  • Pharmaceuticals/medicines/drugs/medicinal products
  • Medical devices
  • Biologics
  • Cosmetics
  • Food and dietary supplements